基因合成市場規模、佔有率和成長分析（按方法、服務、應用、最終用途、地區）：產業預測（2024-2031）

2022年全球基因合成市場規模為21億美元，從2023年的24.4億美元成長到2031年的80.5億美元，在預測期內（2024-2031年）預計複合年成長率為16.1%。

在有利的政府政策和不斷成長的投資興趣的推動下，合成生物市場正在經歷顯著成長。光是 2020 年，該產業就從政府和私人來源吸引了約 80 億美元。 COVID-19 大流行加速了基因合成的機會，研究人員探索新的應用，包括開發合成 SARS-CoV-2 基因片段以增強診斷能力。隨著合成 DNA 技術變得越來越普遍，它為新的病毒威脅和潛在的流行病提供了解決方案。此外，標靶治療、免疫學和化療的協同效應正在吸引生物技術和製藥相關人員的關注，這預示著未來利潤豐厚的商機。然而，這個市場面臨著熟練專業人員短缺的挑戰，公司正在與大學合作培訓計劃，以培養這一重要領域的人才。

目錄

介紹

• 分析目的
• 市場範圍
• 定義

分析方法

• 資訊採購
• 次要/主要資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 市場概況及展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及前景

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考慮因素

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場魅力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 案例研究

全球基因合成市場規模/複合年成長率：依方法分類（2024-2031）

• 市場概況
• 固相合成
• 基於晶片的合成
• 基於PCR的酶合成

全球基因合成市場規模/複合年成長率：依服務分類（2024-2031）

• 市場概況
• 抗體DNA合成
• 病毒DNA合成
• 其他

全球基因合成市場規模/複合年成長率：依應用分類（2024-2031）

• 市場概況
• 疫苗開發
• 治療藥物
• 診斷
• 研究與開發
  • 學術研究
  • 工業研究
• 合成生物學
  • 通路技術（通路技術）
  • 基因組工程

依最終用途分類的全球基因合成市場規模/複合年成長率（2024-2031）

• 市場概況
• 學術研究所
• 生物製藥公司
• 合約研究組織（CRO）

全球基因合成市場規模/複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要企業採取的策略
• 近期市場趨勢
• 主要企業市場佔有率（2023年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Thermo Fisher Scientific Inc. (GeneArt)
• GenScript Biotech Corporation
• Eurofins Genomics
• Integrated DNA Technologies (IDT)
• Twist Bioscience
• ATUM
• Bio Basic Inc.
• SBS Genetech Co. Ltd
• Azenta Life Sciences
• OriGene Technologies Inc.
• Bioneer Corporation
• Genewiz
• Blue Heron Biotech
• Creative Biogene
• SGI-DNA

結論和建議

Global Gene Synthesis Market size was valued at USD 2.1 billion in 2022 and is poised to grow from USD 2.44 billion in 2023 to USD 8.05 billion by 2031, growing at a CAGR of 16.1% during the forecast period (2024-2031).

The synthetic biology market is experiencing significant growth, driven by favorable government policies and increased investment interest. In 2020 alone, the sector attracted approximately USD 8.0 billion from both government and private sources. The COVID-19 pandemic has accelerated opportunities within genetic synthesis, with researchers exploring novel applications, such as the development of synthetic SARS-CoV-2 gene segments to enhance diagnostic capabilities. As synthetic DNA technologies gain traction, they present solutions to emerging viral threats and potential pandemics. Furthermore, the synergy between targeted therapies, immunology, and chemotherapy is attracting attention from biotech and pharmaceutical stakeholders, indicating lucrative opportunities ahead. However, the market faces challenges due to a scarcity of skilled professionals, prompting companies to collaborate with universities for training initiatives to nurture talent in this critical sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Synthesis Market Segmental Analysis

Global Gene Synthesis Market is segmented by method, service, application, end use and region. Based on method, the market is segmented into solid-phase synthesis, chip-based synthesis and PCR-based enzyme synthesis. Based on service, the market is segmented into antibody DNA synthesis, viral DNA synthesis and others. Based on application, the market is segmented into vaccine development, therapeutics, diagnostics, research and development and synthetic biology. Based on end use, the market is segmented into academic and research institutes, biopharmaceutical companies and contract research organizations (CROs) and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Gene Synthesis Market

The global gene synthesis market is primarily driven by the increasing adoption of gene synthesis technologies across a multitude of research and development domains, such as molecular biology, synthetic biology, drug discovery, and genetic engineering. This innovative technology allows researchers to explore gene functions, create genetically modified organisms, devise new therapeutic solutions, and design novel biological systems. As the applications of gene synthesis expand within both academia and industry, its significance in driving scientific advancements becomes more pronounced, ultimately contributing to the growth of the market. The diverse utilization of gene synthesis in cutting-edge research significantly propels its demand.

Restraints in the Global Gene Synthesis Market

The Global Gene Synthesis market faces significant restraints primarily due to ethical and regulatory concerns. The potential for misuse of synthesized genes, which could lead to the creation of harmful pathogens or organisms, raises serious ethical questions. To mitigate these risks, various regulatory frameworks have been established, necessitating strict adherence to ethical guidelines and compliance mandates within the industry. However, these stringent regulations can also hinder market growth by complicating the processes required to obtain necessary approvals and licenses for certain applications. As a result, these challenges can create barriers that slow down innovation and development within the gene synthesis sector.

Market Trends of the Global Gene Synthesis Market

As of October 2023, the Global Gene Synthesis market is witnessing robust growth driven by the surging demand for gene editing and gene therapy technologies, especially with advancements like CRISPR-Cas9. The need for customized DNA constructs is becoming paramount in both experimental research and therapeutic applications, fueling the expansion of gene synthesis services. This intensified focus on precision medicine and genetic modifications is fostering innovation and collaboration among biotech firms, academic institutions, and healthcare providers. Consequently, the gene synthesis sector is positioned for a significant upturn, aligning with broader trends in molecular biology and personalized healthcare solutions globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Case Studies

Global Gene Synthesis Market Size by Method & CAGR (2024-2031)

• Market Overview
• Solid-Phase Synthesis
• Chip-Based Synthesis
• PCR-Based Enzyme Synthesis

Global Gene Synthesis Market Size by Service & CAGR (2024-2031)

• Market Overview
• Antibody DNA Synthesis
• Viral DNA Synthesis
• Others

Global Gene Synthesis Market Size by Application & CAGR (2024-2031)

• Market Overview
• Vaccine Development
• Therapeutics
• Diagnostics
• Research and Development
  • Academic Research
  • Industrial Research
• Synthetic Biology
  • Pathway Engineering
  • Genome Engineering

Global Gene Synthesis Market Size by End Use & CAGR (2024-2031)

• Market Overview
• Academic and Research Institutes
• Biopharmaceutical Companies
• Contract Research Organizations (CROs)

Global Gene Synthesis Market Size & CAGR (2024-2031)

• North America (Method, Service, Application, End Use)
  • USA
  • Canada
• Europe (Method, Service, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Method, Service, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Method, Service, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Method, Service, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific Inc. (GeneArt)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies (IDT)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ATUM
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio Basic Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SBS Genetech Co. Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azenta Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OriGene Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioneer Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genewiz
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Blue Heron Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biogene
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGI-DNA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations